Ching Feng Sun
Directeur/Membre du Conseil chez HUA ENG WIRE & CABLE CO., LTD.
Profil
Ching Feng Sun is the founder and president of Saga-Unitek Ventures, which was founded in 1998.
He is currently the chairman of Kang Chun Venture Capital Co. Ltd., Sai Chia Investment Co. Ltd., Yang Ching Co. Ltd., and Fitek Photonics Corp.
He is also an independent director at Hua Eng Wire & Cable Co., Ltd., Tah Tong Textile Co., Ltd., Wonderful Hi-Tech Co., Ltd., and Chicony Power Technology Co., Ltd.
Additionally, he serves as the general manager and director at Kuo Lien Venture Capital Management Consulting Co. and Sheng Ta Venture Capital Co. Ltd.
He is a director on the supervisory board at LumenMax Optoelectronics Co., Ltd.
and a member of the Taiwan Venture Capital Association.
He is also a director at Signax Technology Capital, Inc. and a member of the supervisory board at Pixon Technologies Corp.
He previously held positions as an independent director at Daitobo Co., Ltd., TWi Pharmaceuticals, Inc., and Emerson Electric (South Asia).
Pte Ltd.
He was also a non-executive director at ASLAN Pharmaceuticals Pte Ltd.
and served as an independent non-executive director at Aslan Pharmaceuticals Ltd.
from 2016 to 2021.
He was a director at Newmax Technology Co., Ltd.
and a member of the supervisory board at Reber Genetics Co., Ltd.
Mr. Sun received a graduate degree from Wayne State University (Michigan), an MBA from the University of Michigan, and an undergraduate degree from National Taipei University of Technology.
Postes actifs de Ching Feng Sun
Sociétés | Poste | Début |
---|---|---|
TAH TONG TEXTILE CO., LTD. | Directeur/Membre du Conseil | 11/06/2015 |
PIXON TECHNOLOGIES CORPORATION | Directeur/Membre du Conseil | 16/06/2011 |
WONDERFUL HI-TECH CO., LTD. | Directeur/Membre du Conseil | 08/06/2010 |
HUA ENG WIRE & CABLE CO., LTD. | Directeur/Membre du Conseil | 17/06/2020 |
CHICONY POWER TECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | 25/08/2021 |
Sai Chia Investment Co. Ltd. | Président | 23/09/2011 |
Signax Technology Capital, Inc. | Directeur/Membre du Conseil | - |
Saga-Unitek Ventures | Fondateur | 01/01/1998 |
Fitek Photonics Corp. | Président | - |
░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Ching Feng Sun
Sociétés | Poste | Fin |
---|---|---|
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Ching Feng Sun
University of Michigan | Masters Business Admin |
National Taipei University of Technology | Undergraduate Degree |
Wayne State University (Michigan) | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 8 |
---|---|
NEWMAX TECHNOLOGY CO., LTD. | Electronic Technology |
TAH TONG TEXTILE CO., LTD. | Process Industries |
DAITOBO CO., LTD. | Finance |
PIXON TECHNOLOGIES CORPORATION | Electronic Technology |
WONDERFUL HI-TECH CO., LTD. | Producer Manufacturing |
ASLAN PHARMACEUTICALS LIMITED | Health Technology |
HUA ENG WIRE & CABLE CO., LTD. | Producer Manufacturing |
CHICONY POWER TECHNOLOGY CO., LTD. | Electronic Technology |
Entreprise privées | 15 |
---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Kuo Lien Venture Capital Management Consulting Co. | |
Sheng Ta Venture Capital Co. Ltd. | |
Hsin Pao Venture Capital Co. Ltd. | |
Kang Chun Venture Capital Co. Ltd. | |
Yang Ching Co. Ltd. | |
Sai Chia Investment Co. Ltd. | |
LumenMax Optoelectronics Co., Ltd.
LumenMax Optoelectronics Co., Ltd. SemiconductorsElectronic Technology LumenMax Optoelectronics Co., Ltd. manufactures light-emitting diode (LED) and LED module. The company's main products are the printed circuit board, plastic leaded chip carrier light emitting device, and module. It focuses on the manufacture of LED packaging components. These devices are used in consumer products, like household appliances, communications and computers. These are also used in light emitting devices, like indoor and outdoor electronic billboards, traffic signals, panel backlight source, and interior lighting. Its business scope includes the manufacture of electronic parts and components, product design industry, trade of telecommunications equipment and electronic materials, as well as international trade. The company was founded on December 26, 2007 and is headquartered in Zhongli, Taiwan. | Electronic Technology |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Taiwan Venture Capital Association | |
Reber Genetics Co., Ltd.
Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
Fitek Photonics Corp. | |
Saga-Unitek Ventures | |
Signax Technology Capital, Inc. | |
Emerson Electric (South Asia) Pte Ltd. |